Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BELLUS Health Inc. (NRM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in Bellus Health Inc.
07/10/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
06/28/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/28/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/28/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/28/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders",
"BELLUS HEALTH INC. REPORT OF VOTING RESULTS"
06/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BELLUS HEALTH INC. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE is hereby given that the annual and special meeting of the common shareholders of BELLUS Health Inc. will be held in person at 275 Armand Frappier Blvd., Laval, Québec, H7V 4A7 on June 30, 2023 at 11:30 a.m., Montréal time, for the following purposes: to receive and consider the annual report of the directors to the shareholders and the financial statements of the Company for the financial year ended December 31, 2022, and the report of the auditors thereon; to elect each of the directors for the ensuing year; to appoint KPMG LLP, Chartered Accountants, as auditors of the Company and to authorize the Audit Committee to fix the auditors’ remuneration; to ratify and confirm the resolution approving t...",
"------- Fold ------- Fold Appointment of Proxyholder I/We being holder of securities of BELLUS Health Inc. hereby appoint: Dr. Francesco Bellini, O.C., or failing this person, Mr. Roberto Bellini, or failing this person, Mr. Ramzi Benamar, or failing this person, Mr. Sébastien Roy OR Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein. as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the holder in accordance with the following direction and on all other matters that may properly come before the Annual and Special Meeting of shareholders of the Company to be held at 275 Armand Frappier Blvd., Laval, Québec, H7V 4A7 on June 30, 2023 at 11:30 am, and at any..."
06/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BELLUS HEALTH INC. NOTICE AND AMENDED AND RESTATED MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL AND SPECIAL MEETING OF COMMON SHAREHOLDERS"
05/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Board of Directors”) of BELLUS Health Inc. invites you to attend a special meeting of the holders of the common shares of the Company (the “Shares",
"BELLUS HEALTH INC. SPECIAL MEETING FRIDAY, JUNE 16, 2023 AT 11:30 A.M. EDT ** ISSUER COPY ** 1 1 07987C204 1 1 51 MERCEDES WAY EDGEWOOD NY 11717 275 Armand-Frappier Blvd. ** Laval, Québec, H7V 4A7 BELLUS HEALTH INC. 275, BOUL. ARMAND-FRAPPIER LAVAL, QC H7V 4A7 CANADA 101010101010101010 11 1011111100100001 1001 10110001100100 100111 110100000111 10110100 0010010100 1010010010 00001111 101100000000 100000 10110010011001 1111 1000000010011000 10 111010010101111011 111101110101101000 1 11001011111110001 111 110111000111110 10110 0010101011101 1000000 00001101010 101100001 111010001 10001111111 0001000 1111111111111 11111 S66563- 10 110 0 0 10 0 0 111 10 110 0 0 10 0 0 111",
"******************************** - 2 - LETTER OF TRANSMITTAL"
05/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BELLUS HEALTH INC 6-K",
"FOR"
05/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Condensed Consolidated Interim Financial Statements (Unaudited) for the periods ended March 31, 2023 and 2022",
"Management’s Discussion and Analysis for the three-month period ended March 31, 2023",
"Form 52-109F2 Certification of Interim Filings – CEO",
"Form 52-109F2 Certification of Interim Filings – CFO"
04/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2023",
"Notice of the Meeting and Record Date"
04/27/2023 6-K Quarterly results
04/18/2023 6-K Quarterly results
04/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BELLUS HEALTH INC. 6-K",
"BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation"
03/29/2023 6-K Quarterly results
03/23/2023 40-F Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
03/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Investor Presentation"
03/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BELLUS HEALTH INC. 6-K",
"BELLUS Health Inc."
03/01/2023 6-K Quarterly results
02/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF FEBRUARY 2023",
"Notice of the Meeting and Record Date"
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 4.2% stake in BELLUS Health Inc.
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 7.1% stake in Bellus Health Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2023 6-K Quarterly results
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/23/2023 SC 13G/A Power Corp of Canada reports a 3.9% stake in Bellus Health Inc.
11/14/2022 6-K Quarterly results
11/14/2022 SUPPL Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
11/14/2022 6-K Quarterly results
11/14/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy